Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Intrinsically Disordered Proteins02:18

Intrinsically Disordered Proteins

19.6K
Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
19.6K
Structure and Function of Platelets01:18

Structure and Function of Platelets

3.7K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
3.7K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

9.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
9.5K
Bone Disorders01:29

Bone Disorders

5.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.5K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

2.3K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.3K
Disorders of Leukocytes01:27

Disorders of Leukocytes

2.0K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Canonical and noncanonical heterotrimeric G-protein signaling in uveal melanoma: Established mechanisms and emerging spindle-orientation hypotheses.

Biochemical pharmacology·2026
Same author

STIMATE-Mustn1 Fusion Protein Prevents Ca<sup>2+</sup> Overload in Cells That Present Increased SOCE.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Orai channels in proliferation, invasion, and chemoresistance of tumor cells.

American journal of physiology. Cell physiology·2026
Same author

Notch1 regulates Orai1 and Orai3 expression in breast cancer cells.

Scientific reports·2025
Same author

Orai1 plays a critical role in Orai3 synthesis and stability in luminal breast cancer cells.

Cell calcium·2025
Same author

EFCAB13 is a Novel Age-Dependent Promotor of SOCE in Blood Platelets and Megakaryoblastic MEG-01 Cells.

Thrombosis and haemostasis·2025

Related Experiment Video

Updated: Feb 11, 2026

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

1.2K

Flavonoids and Platelet-Derived Thrombotic Disorders.

Jose J Lopez1, Mohammed El Haouari2, Isaac Jardin1

  • 1Department of Physiology (Cell Physiology Research Group), University of Extremadura, 10003-Cáceres, Spain.

Current Medicinal Chemistry
|April 19, 2018
PubMed
Summary

Flavonoids, plant compounds found in fruits and vegetables, can inhibit platelet activation. This review explores how these compounds may help prevent thrombotic disorders, such as stroke and deep vein thrombosis.

Keywords:
GPIIb/IIIa receptorPlateletsanti-thrombotic strategiescardiovascular diseaseflavonoidsthrombotic disorders.

More Related Videos

Flavonoid Content During the Growth and Floral Development of Calendula officinalis L.
04:54

Flavonoid Content During the Growth and Floral Development of Calendula officinalis L.

Published on: June 27, 2025

1.1K
Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies
07:06

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies

Published on: January 10, 2025

1.2K

Related Experiment Videos

Last Updated: Feb 11, 2026

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

1.2K
Flavonoid Content During the Growth and Floral Development of Calendula officinalis L.
04:54

Flavonoid Content During the Growth and Floral Development of Calendula officinalis L.

Published on: June 27, 2025

1.1K
Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies
07:06

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies

Published on: January 10, 2025

1.2K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Cardiovascular Science

Background:

  • Thrombotic disorders arise from abnormal clot formation, often involving platelet activation.
  • Platelets are crucial for hemostasis but their dysfunction contributes to cardiovascular diseases like atherosclerosis and stroke.
  • Current anti-thrombotic strategies target platelet activity.

Purpose of the Study:

  • To review the scientific literature on how flavonoids modulate platelet activation.
  • To highlight the role of flavonoids in preventing thrombotic disorders.
  • To focus on the mechanisms by which flavonoids affect platelet events linked to thrombosis.

Main Methods:

  • Literature review of studies on flavonoids and platelet activation.
  • Analysis of research detailing flavonoid effects on platelet signaling pathways.
  • Examination of studies linking flavonoid consumption to cardiovascular health outcomes.

Main Results:

  • Flavonoids inhibit key platelet activation processes, including GPIIb/IIIa receptor function and calcium mobilization.
  • They attenuate the activation of signaling molecules like MAP kinases and phospholipases.
  • Evidence suggests flavonoids reduce the risk of cardiovascular diseases linked to platelet hyperreactivity.

Conclusions:

  • Flavonoids demonstrate significant potential in modulating platelet activity.
  • Their anti-platelet effects offer a promising natural strategy for managing and preventing thrombotic disorders.
  • Further research into flavonoid mechanisms can inform novel therapeutic approaches for cardiovascular disease.